Condition
Acute-on-Chronic Liver Failure (ACLF)
Total Trials
4
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 3 (1)
Trial Status
Not Yet Recruiting3
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07347275Phase 3Not Yet RecruitingPrimary
A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.
NCT07184866Not ApplicableNot Yet RecruitingPrimary
Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial
NCT07178366Not ApplicableNot Yet RecruitingPrimary
Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)
NCT07409259Early Phase 1Active Not RecruitingPrimary
PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure
Showing all 4 trials